547 related articles for article (PubMed ID: 27383479)
21. BRCA1/2 somatic mutation detection in formalin-fixed paraffin embedded tissue by next-generation sequencing in Korean ovarian cancer patients.
Lee A; Kang J; Lee H; Lee YS; Choi YJ; Lee KH; Nistala GJ; Scafe CR; Choi J; Yoo J; Han M D E; Kim Y; Kim M
Pathol Res Pract; 2019 Nov; 215(11):152595. PubMed ID: 31570282
[TBL] [Abstract][Full Text] [Related]
22. Rapid and cost-effective high-throughput sequencing for identification of germline mutations of BRCA1 and BRCA2.
Ahmadloo S; Nakaoka H; Hayano T; Hosomichi K; You H; Utsuno E; Sangai T; Nishimura M; Matsushita K; Hata A; Nomura F; Inoue I
J Hum Genet; 2017 Apr; 62(5):561-567. PubMed ID: 28179634
[TBL] [Abstract][Full Text] [Related]
23. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
[TBL] [Abstract][Full Text] [Related]
24. Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer.
Ozcelik H; Shi X; Chang MC; Tram E; Vlasschaert M; Di Nicola N; Kiselova A; Yee D; Goldman A; Dowar M; Sukhu B; Kandel R; Siminovitch K
J Mol Diagn; 2012 Sep; 14(5):467-75. PubMed ID: 22874498
[TBL] [Abstract][Full Text] [Related]
25. GeneReader NGS System Is a Useful Sequencing Platform for Clinical Testing of
Lee EJ; Kim HK; Ahn S; Lee YJ; Kim J; Lee SW; Lee JW; Lee W; Kim HS; Chun S; Son BH; Jung KH; Kim YM; Min WK; Ahn SH
Ann Clin Lab Sci; 2020 Jan; 50(1):107-118. PubMed ID: 32161019
[TBL] [Abstract][Full Text] [Related]
26. NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial.
Endris V; Stenzinger A; Pfarr N; Penzel R; Möbs M; Lenze D; Darb-Esfahani S; Hummel M; Sabine-Merkelbach-Bruse ; Jung A; Lehmann U; Kreipe H; Kirchner T; Büttner R; Jochum W; Höfler G; Dietel M; Weichert W; Schirmacher P
Virchows Arch; 2016 Jun; 468(6):697-705. PubMed ID: 27003155
[TBL] [Abstract][Full Text] [Related]
27. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis of the breast cancer genes BRCA1 and BRCA2 using amplicon-based massive parallel pyrosequencing.
Michils G; Hollants S; Dehaspe L; Van Houdt J; Bidet Y; Uhrhammer N; Bignon YJ; Vermeesch JR; Cuppens H; Matthijs G
J Mol Diagn; 2012 Nov; 14(6):623-30. PubMed ID: 23034506
[TBL] [Abstract][Full Text] [Related]
29. Molecular analysis of BRCA1 and BRCA2 genes by next generation sequencing and ultrastructural aspects of breast tumor tissue.
Mihalcea CE; Moroşanu AM; Murăraşu D; Puiu L; Cinca SA; Voinea SC; Mirancea N
Rom J Morphol Embryol; 2017; 58(2):445-455. PubMed ID: 28730229
[TBL] [Abstract][Full Text] [Related]
30. Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes.
Feliubadaló L; Lopez-Doriga A; Castellsagué E; del Valle J; Menéndez M; Tornero E; Montes E; Cuesta R; Gómez C; Campos O; Pineda M; González S; Moreno V; Brunet J; Blanco I; Serra E; Capellá G; Lázaro C
Eur J Hum Genet; 2013 Aug; 21(8):864-70. PubMed ID: 23249957
[TBL] [Abstract][Full Text] [Related]
31. Streamlined ion torrent PGM-based diagnostics: BRCA1 and BRCA2 genes as a model.
Tarabeux J; Zeitouni B; Moncoutier V; Tenreiro H; Abidallah K; Lair S; Legoix-Né P; Leroy Q; Rouleau E; Golmard L; Barillot E; Stern MH; Rio-Frio T; Stoppa-Lyonnet D; Houdayer C
Eur J Hum Genet; 2014 Apr; 22(4):535-41. PubMed ID: 23942203
[TBL] [Abstract][Full Text] [Related]
32. BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report.
Pilato B; Pinto R; De Summa S; Petriella D; Lacalamita R; Danza K; Paradiso A; Tommasi S
Genes Chromosomes Cancer; 2016 Oct; 55(10):803-13. PubMed ID: 27225819
[TBL] [Abstract][Full Text] [Related]
33. Post-mortem testing; germline BRCA1/2 variant detection using archival FFPE non-tumor tissue. A new paradigm in genetic counseling.
Petersen AH; Aagaard MM; Nielsen HR; Steffensen KD; Waldstrøm M; Bojesen A
Eur J Hum Genet; 2016 Aug; 24(8):1104-11. PubMed ID: 26733283
[TBL] [Abstract][Full Text] [Related]
34. Massive Parallel Sequencing for Diagnostic Genetic Testing of BRCA Genes--a Single Center Experience.
Ermolenko NA; Boyarskikh UA; Kechin AA; Mazitova AM; Khrapov EA; Petrova VD; Lazarev AF; Kushlinskii NE; Filipenko ML
Asian Pac J Cancer Prev; 2015; 16(17):7935-41. PubMed ID: 26625824
[TBL] [Abstract][Full Text] [Related]
35. Next generation sequencing analysis of BRCA1 and BRCA2 identifies novel variations in breast cancer.
Yildiz Tacar S; Bozgeyik E; Seber ES; Yetisyigit T; Tozkir H; Avci O; Arslan A
Life Sci; 2020 Nov; 261():118334. PubMed ID: 32846166
[TBL] [Abstract][Full Text] [Related]
36. Benchmarking of Amplicon-Based Next-Generation Sequencing Panels Combined with Bioinformatics Solutions for Germline BRCA1 and BRCA2 Alteration Detection.
Vendrell JA; Vilquin P; Larrieux M; Van Goethem C; Solassol J
J Mol Diagn; 2018 Nov; 20(6):754-764. PubMed ID: 30055349
[TBL] [Abstract][Full Text] [Related]
37. BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study.
Kowalik A; Siołek M; Kopczyński J; Krawiec K; Kalisz J; Zięba S; Kozak-Klonowska B; Wypiórkiewicz E; Furmańczyk J; Nowak-Ozimek E; Chłopek M; Macek P; Smok-Kalwat J; Góźdź S
PLoS One; 2018; 13(7):e0201086. PubMed ID: 30040829
[TBL] [Abstract][Full Text] [Related]
38. Characterization of BRCA1 and BRCA2 genetic variants in a cohort of Bahraini breast cancer patients using next-generation sequencing.
Al Hannan F; Keogh MB; Taha S; Al Buainain L
Mol Genet Genomic Med; 2019 Jul; 7(7):e00771. PubMed ID: 31131559
[TBL] [Abstract][Full Text] [Related]
39. Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform.
Chan M; Ji SM; Yeo ZX; Gan L; Yap E; Yap YS; Ng R; Tan PH; Ho GH; Ang P; Lee AS
J Mol Diagn; 2012 Nov; 14(6):602-12. PubMed ID: 22921312
[TBL] [Abstract][Full Text] [Related]
40. Genetic testing in hereditary breast and ovarian cancer using massive parallel sequencing.
Ruiz A; Llort G; Yagüe C; Baena N; Viñas M; Torra M; Brunet A; Seguí MA; Saigí E; Guitart M
Biomed Res Int; 2014; 2014():542541. PubMed ID: 25136594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
